FDA Takes Steps to Streamline Path for COVID-19 Screening Tools, Provides Information to Help Groups Establishing Testing Programs

Home / Articles / External Government


March 22, 2021 | Originally published by U.S. Food and Drug Administration (FDA) on March 16, 2021

Testing remains an important cornerstone of our nation’s fight against COVID-19. This includes schools, workplaces, communities and other locations using testing to screen asymptomatic individuals who may still spread the virus. Screening involves testing asymptomatic individuals who do not have known or suspected exposure to COVID-19 in order to make individual decisions, such as whether an individual should participate in an activity, based on the test results.

Focus Areas

Want to find out more about this topic?

Request a FREE Technical Inquiry!